Partner, DRG Consulting
John Jaeger, a Partner leading DRG Consulting’s US Market Access Practice, is a commercial strategy consultant with a strong track record of client service and US pricing, reimbursement, and market access expertise. In particular, John has a strong interest and focus in partnering with clients on the development and implementation of innovative segment-based engagement, successful market entry, and post-launch optimization.
For over 10 years, John has worked across the US healthcare landscape on a variety of topics including healthcare reform, product launch, portfolio and life-cycle management, pricing and contract strategy, and regional influence mapping. As part of DRG Consulting, John has supported a wide range of clients from top 10 pharma manufacturers to pre-clinical start-ups. While engaging a broad array of therapeutic areas, John has successfully executed over a dozen US and Globally focused market access engagements within the HIV therapeutic arena.
Outside of DRG Consulting, John has presented at multiple leading industry conferences regarding biosimilar commercial strategy and evolving benefit design structures. John is an adjunct professor for the University of Sciences MBA program and is a guest lecturer for the Rutgers MBA program. In addition, John serves on the Leadership Board for the Cancer Support Community’s Research and Training Institute.
John completed a MPA in Public Health at the University of Delaware and holds a BS in Public Administration from Shippensburg University